$191,948
＋2.1%
Chief Financial Officer
2023
$192k
40 hrs/wk
Chief Financial Officer at Foundation for Angelman Syndrome Therapeutics
Fiscal year ended December 31, 2023. Published on January 25, 2026.
Total compensation
Kena Richert has been listed as an employee of Foundation for Angelman Syndrome Therapeutics in Form 990 filings since fiscal year 2020. Total compensation for Kena Richert has increased by 84.3% from 2020 to 2023.